[1]董红艳,刘晓春,刘英杰.中医三联疗法联合融入ERAS理念的临床护理路径在胃癌围术期患者中的应用效果分析[J].西部中医药,2024,37(11):133-136.[doi:10.12174/j.issn.2096-9600.2024.11.29]
　DONG Hongyan,LIU Xiaochun,LIU Yingjie.Effects of TCM Triple Therapy Combined with ERAS-based Clinical Care Path on Patients Suffering Gastric Cancer in the Perioperative Period[J].Western Journal of Traditional Chinese Medicine,2024,37(11):133-136.[doi:10.12174/j.issn.2096-9600.2024.11.29]
点击复制

中医三联疗法联合融入ERAS理念的临床护理路径在胃癌围术期患者中的应用效果分析
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
37
期数:
2024年11期
页码:
133-136
栏目:
临床研究
出版日期:
2024-11-15

文章信息/Info

Title:
Effects of TCM Triple Therapy Combined with ERAS-based Clinical Care Path on Patients Suffering Gastric Cancer in the Perioperative Period
作者:
董红艳1, 刘晓春1, 刘英杰2
1.北京市平谷区中医医院，北京 101200
2.北京市平谷区医院，北京 101200
Author(s):
DONG Hongyan1, LIU Xiaochun1, LIU Yingjie2
1.Pinggu District Hospital of TCM, Beijing 101200, China
2.Pinggu District Hospital, Beijing 101200, China
关键词:
胃癌; 中医三联疗法; 热罨包; 针刺; 情志护理; ERAS理念; 围术期
Keywords:
gastric cancer; TCM triple therapy; Chinese herbal salt packets; needling; emotional care; ERAS concept; perioperative period
分类号:
R248.2
DOI:
10.12174/j.issn.2096-9600.2024.11.29
文献标志码:
B
摘要:
目的分析中医三联疗法联合融入加速康复外科（enhanced recovery after surgery，ERAS）理念的临床护理路径对胃癌围术期患者的影响。 方法选取54例胃癌手术患者为研究对象，按照随机数字表法分为对照组和观察组各27例，对照组采用常规护理干预，观察组在对照组基础上加用中医三联疗法联合融入ERAS理念的临床护理路径，比较两组干预效果。 结果观察组肛门排气时间、胃管拔除时间、首次下床活动时间均短于对照组（P＜0.05）；手术前1天、首次下床活动时、出院时观察组心理痛苦温度计（dis-tress thermometer，DT）评分均低于对照组（P＜0.05）；观察组并发症发生率［7.4%（2/27）］低于对照组［29.6%（8/27）］（P＜0.05），术前1天、术后15天视觉模拟评分量表评分均低于对照组（P＜0.05），患者满意度高于对照组（P＜0.05）。 结论在胃癌患者围术期应用中医三联疗法联合融入ERAS理念的临床护理路径，能够促进胃癌术后患者胃肠功能恢复，改善其心理状况，降低疼痛程度和并发症发生率，提高患者满意度。
Abstract:
ObjectiveTo analyze the influence of TCM triple therapy and ERAS-based clinical nursing path on the patients with gastric cancer in the perioperative period. MethodsAll 54 patients who underwent the surgery of gastric cancer were chosen as the subjects, and they were allocated to the control group and the observation group according to random number table method with 27 cases in each group, the control group adopted routine nursing intervention, and the observation group used TCM triple therapy and ERAS-based clinical nursing path on the foundation of the therapy the control group accepted, to compare the intervention effects between both groups. ResultsThe observation group was shorter than the control group in anal exhaust time, gastric tube removal time and the time of first off-bed activity (P<0.05); DT scores on one day before the surgery, the time of first off-bed activity and at the time of discharging of the observation group were lower than these of the control group (P<0.05); the complications of the observation group was [7.4%(2/27)], lower than [29.6%(8/27)] of the control group (P<0.05). VAS scores on one day before the surgery and 15 days after the surgery were lower than these of the control group (P<0.05). The observation group was higher than the control group in the satisfactory degrees (P<0.05). ConclusionTCM triple therapy and ERAS-based clinical nursing path on the patients with gastric cancer in the perioperative period could promote gastrointestinal recovery, improve psychological state, decrease pain degrees and the incidences of complications as well as increase the patients' satisfactory degree.

相似文献/References:

[1]熊墨年,唐晓玲,余炅,等.益气清毒法联合化疗治疗中晚期胃癌的临床观察[J].西部中医药,2011,24(11):35.
[2]张小仙,倪角角,陈辉.舒适护理在晚期胃癌患者中的应用[J].西部中医药,2012,25(12):105.
　ZHANG Xiao-xian,NI Jiao-jiao,CHEN Hui.Application of Comfort Care to the Patients with Gastric Cancer at Advanced Stage[J].Western Journal of Traditional Chinese Medicine,2012,25(11):105.
[3]王宏伟,程小丽,许雅清,等.苦马豆素对胃癌细胞中pten和survivin mRNA表达的影响[J].西部中医药,2015,28(12):25.
[4]胡玥,刘沈林.刘沈林教授“胃肾同治”理论探讨及其在胃癌中的应用[J].西部中医药,2015,28(10):72.
[5]朱剑梅,李世军.莲芪胶囊配合化疗治疗胃癌的临床研究[J].西部中医药,2015,28(12):91.
[6]李雅娟.围手术期护理对胃癌根除术患者护理质量的影响[J].西部中医药,2012,25(12):113.
　LI Ya-juan.Influence of Perioperative Care on Nursing Quality of Patients Undergoing Radical Resection of Gastric Cancer[J].Western Journal of Traditional Chinese Medicine,2012,25(11):113.
[7]刘河,刘超,杨世勇.胃癌中医证型与病灶组织中MMP-9、TIMP-2和HER-2表达的相关性分析[J].西部中医药,2017,30(02):134.
　LIU He,LIU Chao,YANG Shiyong.Correlation Analysis btween TCM Syndrome of Gastric Cancer and the Expression of MMP-9, TIMP-2 and HER-2 in Focus Tissue[J].Western Journal of Traditional Chinese Medicine,2017,30(11):134.
[8]王志新,邹玺,胡守友.中药抗胃癌的现代药理机制[J].西部中医药,2016,29(04):137.
　WANG Zhixin,ZOU Xi,HU Shouyou.Modern Pharmacological Mechanism of Herbs Fighting against Gastric Cancer[J].Western Journal of Traditional Chinese Medicine,2016,29(11):137.
[9]白兆琴,王惠霞,王宏伟△.黄芩苷对胃癌SGC-7901细胞TLR8、HIF-1α、PDGFβ和pten表达的影响[J].西部中医药,2017,30(08):12.
　BAI Zhaoqin,WANG Huixia,WANG Hongwei.The Effects of Baicalin on the Expression of TLR8, HIF-1α, PDGFβ and pten of Gastric Cancer SGC-7901 Cells[J].Western Journal of Traditional Chinese Medicine,2017,30(11):12.
[10]王亚峰,谢亲建,丁晓煜,等.白刺对胃癌MGC-803细胞的抑制作用[J].西部中医药,2018,31(05):14.
　WANG Yafeng,XIE Qinjian,DING Xiaoyu,et al.Study of Inhibitory Action of BaiCi on Gastric Cancer MGC-803 Cells[J].Western Journal of Traditional Chinese Medicine,2018,31(11):14.

备注/Memo

备注/Memo:
董红艳（1979—），女，主管护师。研究方向：胃肠肿瘤围手术期临床护理、肠内外营养支持、创伤急救及中医临床疗护、健康指导。E-mail：dhy760904@126.com。北京市科技计划项目（Zyy2019-04）。
更新日期/Last Update: 2024-11-15